Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 August 2025 | Story Igno van Niekerk | Photo Stephen Collett
One-Room Space
The UFS’ one-room spaces are designed to connect students and lecturers seamlessly across locations and borders.

The university is transforming education across its Bloemfontein, Qwaqwa, and South campuses with its pioneering one-room spaces, mirrored across all three locations to deliver cutting-edge, immersive learning. Research for these innovative spaces began in 2023, sparked by a photo from the University of Leuven in Belgium, which the university identified as showcasing Leuven’s advanced classroom setup. Prof Philippe Burger, Dean of the Faculty of Economic and Management Sciences, leveraging a connection there, led a team to explore this technology globally, collaborating with Canada’s X2O OneRoom to make the UFS the first in South Africa – and one of (as far as we know) two in Africa, alongside Kenya – to offer such immersive classrooms.

Unlike Zoom or Blackboard, where online students were often overlooked as small icons, one-room spaces ensure that everyone feels included. Designed for postgraduate training and PhD interactions, these rooms accommodate up to 40 in-person and 40 online participants, with large video camera feeds on screens, reminiscent of the TV programme Small Talk, where children’s faces lined the wall for engagement. Directional audio and personal cameras create a sensory experience, with sound coming from the speaker’s direction and eye contact feeling natural. Angelique Carson-Porter from the Department of Nutrition and Dietetics shared her excitement about a postgraduate session led by Prof Aletta Olivier, Lecturer in the Centre for Gender and Africa Studies: “It feels like you’re right there, even from Pretoria or Ghana. You see everyone, interact, and never miss a beat.”

Gavin Coetzer at ICT Services, a key project leader, highlighted how lecturers struggled with older platforms’ limitations, often only addressing online questions at the end, disrupting the flow. The UFS’ one-room spaces, implemented in the UFS Business School, the Clinical Skills Unit, South Campus teacher training, and Qwaqwa, solve this with breakout sessions and global conference support. While other universities rely on Teams, the UFS’ user-friendly tech, with around 24 screens and ceiling microphones, allows lecturers to focus on teaching.

Staying ahead of tech trends is challenging, but the university is excelling, making education inclusive, engaging, and truly global.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept